Genomatica, which has developed a platform to convert renewable feedstocks into chemicals used in various consumer products, including athletic apparel, running shoes, electronics and automobiles, filed an S-1 registration filing with the SEC on Wednesday. The San Diego, CA-based company has attracted funding from a number of venture capital firms and plans to raise up to an additional $100 million in an initial public offering to support its R&D efforts and to fund capital expenditures.
Genomatica is following the footsteps of several other recently public companies specializing in the conversion of food and non-food resources into energy and chemicals, such as KiOR, Solazyme, Amyris and Gevo, which have been received by investors with mixed results. The firm plans to list on the NASDAQ under the symbol GENO and has selected Morgan Stanley, J.P. Morgan, and Jefferies to be the lead underwriters on the deal. Terms and timing for the offering have yet to be announced.
